How relevant is Franco Basaglia currently? Psychiatrists, psychotherapists and the reduced life expectancy of psychiatric patients

Authors

  • Peter Lehmann

Abstract

The author investigates the current relevance of the Italian reform psychiatrist Franco Basaglia who died in 1980. In spite of the massively reduced life expectancy of psychiatric patients, psychiatric drugs are administered without obtaining informed consent and without clarifying the early warning signs, which point to permanent or fatal treatment damage. By not taking a critical approach and sponsored by the pharmaceutical industry, psychiatrists and psychologists advocate within the framework of psycho-education the continuous intake of psychiatric drugs and praise new substances untruthfully as having only few side-effects. Basaglia’s statement about intellectuals’ “Crimini di Pace” (crimes of pacification) is currently very relevant. It asks the question not only about moral responsibility but also about civil and criminal steps to be taken.

Keywords: Psychotherapy research, psychotherapy process, therapist variables, unwanted effects of psychotherapy, psychotherapeutic faults

Author Biography

Peter Lehmann

Peter Lehmann ist Diplom-Sozialpädagoge und betreibt den Antipsychiatrieverlag in Berlin. Eigene Buchpublikationen: »Der chemische Knebel – Warum Psychiater Neuroleptika verabreichen«, »Psychopharmaka absetzen – Erfolgreiches Absetzen von Neuroleptika, Antidepressiva, Phasenprophylaktika, Ritalin und Tranquilizern«, »Statt Psychiatrie« u.v.m. Mehr siehe www.peter-lehmann.de

Downloads

Published

2013-03-30

How to Cite

Lehmann, P. (2013). How relevant is Franco Basaglia currently? Psychiatrists, psychotherapists and the reduced life expectancy of psychiatric patients. Psychotherapie-Wissenschaft, 3(2), 79–89. Retrieved from https://psychotherapie-wissenschaft.info/article/view/169

Issue

Vol. 3 No. 2 (2013): Freie Themen

Section

Original Work

License

This journal provides open access to its content in accordance with the basic premise that the free public availability of research benefits the exchange of knowledge throughout the world.

Authors wishing to publish in this journal agree to the following:

  1. The author/s retain/s the copyrights and consent/s to initial publication of the work in the journal under a Creative Commons Attribution licence, which allows third parties to use the work by citing the name/s of the author/s and this journal as initial publisher (in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 DE-Licence).
  1. The author/s can enter into additional contracts for the non-exclusive distribution (e.g. publish in a collection or book) of the version published in the journal, if the journal is cited as initial publisher.